The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity
<p>Abstract</p> <p>Background</p> <p>the mainstay of treatment of polymyalgia rheumatica (PMR) is oral glucocorticoids, but randomized controlled trials of treatment are lacking. As a result, there is no evidence from controlled studies on the efficacy of different initial doses or glucocorticoid ta...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2011-05-01
|
| Schriftenreihe: | BMC Musculoskeletal Disorders |
| Schlagworte: | |
| Online-Zugang: | http://www.biomedcentral.com/1471-2474/12/94 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|